CCSD Code S0607: Photodynamic Therapy to Malignant Skin Lesion

Key Takeaways

CCSD code S0607 covers photodynamic therapy applied to four or more malignant skin lesions in a single session.

S0605, S0606, and S0607 form a tiered PDT family – selecting the correct code requires an accurate lesion count before billing.

Most UK private insurers require pre-authorisation before PDT treatment; confirm requirements with each insurer before the appointment.

Pair S0607 with a supporting ICD-10 code – typically from the C44, D04, or L57 families – to demonstrate clinical necessity.

Accurate documentation of lesion count, photosensitising agent, and treatment sites is essential to avoid claim rejection.

CCSD Code S0607 Photodynamic Therapy: Code Definition and Clinical Scope

Private dermatology practices billing for photodynamic therapy need to apply the correct CCSD code to avoid claim rejection – and lesion count is the deciding factor. CCSD code S0607 photodynamic therapy malignant skin lesion covers the application of photodynamic therapy to four or more malignant lesions of the skin within a single treatment session. It sits at the top of a three-code PDT family maintained by the Clinical Coding and Schedule Development (CCSD) Group, the body responsible for procedure codes used across UK private medical insurance billing.

Photodynamic therapy is a light-activated treatment in which a photosensitising agent – most commonly 5-aminolevulinic acid (5-ALA) or methyl aminolevulinate (MAL) – is applied topically to the lesion site and then activated by a specific wavelength of light. The photochemical reaction selectively destroys abnormal cells while leaving surrounding tissue largely intact. According to the British Association of Dermatologists (BAD), PDT is a clinically established treatment for several cutaneous malignant and pre-malignant conditions and is widely used in both NHS and private dermatology settings.

The CCSD schedule structures PDT billing by the number of lesions treated in a session. Getting the threshold right is not a technicality – it is the fundamental basis of the claim. S0607 applies specifically when four or more malignant lesions are treated. Any session treating fewer lesions must use a different code from the same family, as detailed in the section on adjacent codes below.

CCSD Code S0607 Photodynamic Therapy: Eligible Conditions and Diagnoses

Not every skin lesion qualifies as a malignant lesion for S0607 billing purposes. The code applies to conditions where PDT has established clinical evidence and is indicated within recognised treatment guidelines. NICE guidance and BAD clinical guidelines both support PDT for three primary diagnoses in the malignant and pre-malignant category.

Actinic Keratosis (AK)

Actinic keratoses are pre-malignant lesions arising from cumulative UV exposure. They carry a recognised risk of progression to squamous cell carcinoma, which justifies their classification within the malignant disease framework for insurance billing purposes. PDT is one of the most effective field-treatment options when a patient presents with multiple lesions across an area – a common scenario in patients with significant solar damage. When AK is the primary diagnosis, the appropriate ICD-10 code is from the L57 family (skin changes due to chronic exposure to non-ionising radiation), with L57.0 specifically covering actinic keratosis.

Bowen’s Disease (Squamous Cell Carcinoma In Situ)

Bowen’s disease is a form of intraepidermal squamous cell carcinoma and is classified as carcinoma in situ of the skin. PDT is well-established for Bowen’s disease, particularly for thin lesions on the lower leg where surgical options carry higher complication risks. The relevant ICD-10 code family is D04 (carcinoma in situ of skin), with D04.9 or a more specific D04 subcode used depending on the anatomical site. When multiple Bowen’s lesions are treated in one session, S0607 applies directly.

Superficial Basal Cell Carcinoma (sBCC)

Superficial basal cell carcinoma is the form of BCC for which PDT is indicated – not nodular or infiltrative subtypes, where surgical excision or Mohs micrographic surgery is standard. For sBCC, PDT is appropriate when lesions are multiple, thin, and in cosmetically or surgically challenging sites. The ICD-10 code is C44 (malignant neoplasm of skin, other and unspecified), with site-specific subcodes applied. Clinical documentation must confirm the superficial histological subtype to support the claim.

When billing CCSD code S0607 photodynamic therapy malignant skin lesion, the clinical notes must record which diagnosis applies to each treated lesion. Insurers reviewing claims against NICE clinical guidance will assess whether PDT was the appropriate treatment modality for the specific lesion type documented.

CCSD Codes S0605, S0606, and S0607: Understanding the PDT Code Family

The CCSD PDT code family is structured around a single variable: the number of malignant skin lesions treated in one session. Selecting the wrong code – even when the treatment itself is entirely appropriate – is one of the most common reasons PDT claims are returned or queried by UK insurers. The three codes work as follows, based on the CCSD schedule naming convention.

The threshold between S0606 and S0607 is the treatment of a fourth lesion. When a patient presents with three lesions at one visit and a fourth lesion is identified and treated in the same session, S0607 must be used – not S0606. The lesion count refers to the number of distinct lesions treated with PDT in a single visit, not the total number of lesions present on the patient.

Practices using claims management software that links clinical notes to billing can reduce the risk of miscoding by tying the documented lesion count directly to the code selected at invoicing. When the clinical record clearly states “four lesions treated with PDT”, the billing step becomes a verification rather than a guess.

It is worth noting that these codes are procedure codes, not drug codes. The cost of the photosensitising agent (5-ALA or MAL) is typically billed separately, either as a drug charge or within a bundled treatment fee – check individual insurer fee schedules, as policies vary. The CCSD Technical Guide provides authoritative guidance on bundling rules and any code-specific billing restrictions.

CCSD Code S0607: Documentation Requirements for UK Private Insurers

Submitting a claim for CCSD code S0607 photodynamic therapy malignant skin lesion without adequate supporting documentation is the fastest route to a denial or a request for clinical records. UK private insurers – including Bupa, AXA Health, Aviva, Vitality Health, WPA, and Cigna UK – all require that procedure claims are backed by contemporaneous clinical notes that demonstrate both the clinical necessity and the accuracy of the code selected.

CCSD Code S0607 Documentation: Core Clinical Record Requirements

Every S0607 claim should be supported by a clinical record that contains the following elements. First, the primary diagnosis, recorded using the appropriate ICD-10 code – this is the link between the clinical presentation and the treatment justification. Second, the total number of lesions treated in the session must be explicitly stated; “multiple lesions” is insufficient when the code selection depends on an exact threshold. Third, the anatomical sites of all treated lesions should be recorded, as insurers may cross-reference this with follow-up documentation.

Fourth, the photosensitising agent used – 5-ALA or MAL – along with the application time and light source parameters, should appear in the treatment record. Fifth, the clinician’s name and GMC registration number must be on the invoice. Most insurers will also require the referring practitioner’s details if the patient was referred for PDT rather than presenting for a self-managed condition.

ICD-10 Codes Paired with CCSD Code S0607

UK private insurers require a supporting diagnosis code on every claim. For CCSD code S0607 photodynamic therapy malignant skin lesion, the ICD-10 code must reflect the actual clinical diagnosis of the treated lesions. The most commonly paired codes are set out below.

The ICD-10 code should reflect the primary treated condition. If a patient has both actinic keratoses and a Bowen’s lesion treated in the same session, document the primary diagnosis and note the additional diagnosis in the clinical record. The NHS Classifications Browser allows practitioners to verify current UK ICD-10 fifth edition codes before submission.

Manage CCSD billing and clinical documentation in one place

Pabau helps private dermatology practices link clinical notes directly to billing codes, reducing claim errors and supporting accurate CCSD code submission for treatments including photodynamic therapy.

Book a demo

CCSD Code S0607 Photodynamic Therapy: Pre-Authorisation and Insurer Requirements

Pre-authorisation is required by most UK private medical insurers before PDT is carried out on malignant skin lesions. Proceeding without authorisation – even when the treatment is clinically appropriate and the code selection is accurate – means the insurer may decline the claim entirely. Practices billing for CCSD code S0607 photodynamic therapy malignant skin lesion should build pre-authorisation into the standard patient pathway before the treatment session is booked.

CCSD Code S0607 Billing: Insurer-Specific Guidance

Each UK insurer operates its own provider portal and has its own pre-authorisation and fee schedule policies. Coverage terms vary by policy year and individual plan type, so the guidance below reflects general practice rather than a definitive statement of any insurer’s current policy. Always confirm with the relevant insurer before treatment.

Bupa: Bupa uses its own CCSD-mapped code search tool, available at the Bupa code search portal, which allows practitioners to verify code acceptance and associated fee information. Pre-authorisation for PDT is generally required before treatment; the referring dermatologist’s details and the diagnosis code should be provided at the point of authorisation request. Pabau’s dedicated Bupa CCSD codes guide covers Bupa’s procedure code structure in detail.

AXA Health: AXA Health publishes its specialist procedure codes and fee chapters through its AXA Health specialist procedure codes portal. CCSD-coded invoices should be submitted through the appropriate channel with the authorisation reference number included. AXA Health typically requires a specialist referral before authorising dermatological treatments.

Aviva: Aviva’s Aviva fee schedule operates on a CCSD-based structure. Practitioners should check the schedule for S0607 fee levels before quoting patients, as fees may differ from those set by other insurers. The Aviva invoicing requirements guide sets out submission rules for CCSD-coded claims.

Vitality Health: Vitality Health publishes its procedure fees through the Vitality fee finder, where S0607 fees can be looked up directly by code. Pre-authorisation processes are described in the Vitality provider portal.

WPA: WPA operates outside the main insurer group for some fee schedule purposes. WPA’s medical fees page provides information on reimbursement levels and the documentation required to support specialist claims.

Many UK private practices submit CCSD-coded claims electronically through Healthcode, the billing network used by a significant proportion of UK private practitioners. Healthcode validates claim format and code structure before submission, which helps catch coding errors before they reach the insurer. Electronic submission typically results in faster processing and reduces the risk of lost paperwork. For practices managing private dermatology workflows, integrating Healthcode-compatible billing with clinical documentation software reduces the manual handoff between treatment records and invoicing.

CCSD Code S0607 Photodynamic Therapy: Billing Workflow and Common Claim Errors

CCSD Code S0607 Billing Workflow: From Referral to Paid Claim

A reliable billing workflow for CCSD code S0607 photodynamic therapy malignant skin lesion follows a consistent sequence that begins before the patient attends for treatment. The steps below reflect best practice for UK private dermatology settings.

1. Confirm insurance cover and pre-authorise: Before booking the PDT appointment, contact the patient’s insurer or use the relevant provider portal to confirm that PDT to malignant skin lesions is covered under the patient’s plan. Obtain a pre-authorisation reference number and record it in the patient file.
2. Document lesion count at the clinical assessment: At the assessment or consultation prior to PDT, document the number of lesions planned for treatment in the clinical record. This creates an audit trail linking the clinical assessment to the treatment session.
3. Record treatment details contemporaneously: During the PDT session, record in the clinical note: diagnosis per lesion, number of lesions treated, anatomical sites, photosensitising agent used, and light source parameters. Post-hoc documentation is difficult to defend if a claim is queried.
4. Select the correct CCSD code: Confirm the lesion count against the PDT code family: S0605 for one lesion, S0606 for two to three, and S0607 for four or more. Apply the appropriate ICD-10 diagnosis code alongside the CCSD procedure code.
5. Submit via Healthcode or insurer portal: Include the pre-authorisation reference, GMC number, CCSD code S0607, and the supporting ICD-10 code. Retain a copy of the submitted claim for your records.

Practices using integrated practice management software can link each step in this workflow – from the clinical note to the billing record – within a single system. This reduces re-keying errors and ensures the claim reflects what is actually documented in the patient record.

CCSD Code S0607: Common Claim Errors and How to Avoid Them

Several recurring errors lead to S0607 claims being queried, delayed, or rejected by UK private insurers. Understanding them allows practices to address the underlying process gaps rather than chasing individual claim resolutions.

Wrong code from the PDT family: Using S0606 when four lesions were treated, or S0607 when only three were treated, is the single most frequent coding error. The fix is documentation-led: the clinical note must state the lesion count explicitly before billing begins.

Missing or mismatched ICD-10 code: A claim submitted with no diagnosis code, or a diagnosis code that does not clinically correspond to a condition for which PDT is indicated, will be queried. “Actinic keratosis” documented in the notes but “unspecified skin disorder” entered on the invoice creates an immediate discrepancy.

No pre-authorisation reference: Submitting a claim without a valid pre-authorisation number – where the insurer requires one – is a straightforward rejection trigger. Many insurers will not process the claim even if everything else is correct.

Incorrect bundling of drug costs: Billing the photosensitising agent separately when the insurer fee schedule includes it within the procedure code, or failing to bill it separately when the schedule excludes it, leads to queries. Check each insurer’s fee schedule rules before invoicing.

Practices running a regular clinical compliance review of their billing records can identify these patterns before they accumulate into a pattern of claim failures. A quarterly audit of PDT claims – checking code selection against documented lesion counts – typically surfaces coding drift before it becomes a systemic problem.

CCSD Code S0607 in Practice: Managing PDT Billing for UK Private Dermatology

The administrative dimension of PDT billing goes beyond selecting the right code at invoicing time. Practices seeing regular volumes of PDT patients – particularly those managing older patients with extensive actinic damage or field cancerisation – need a consistent workflow that handles the variation in session-by-session lesion counts without introducing coding inconsistencies.

One practical approach is to create a standardised PDT treatment record template that includes a mandatory field for the number of lesions treated, mapped directly to the S0605/S0606/S0607 code family. When a clinician completes the treatment record and selects “4+” in the lesion count field, the billing system can pre-populate S0607 for review rather than requiring the billing administrator to interpret freetext notes. This reduces the cognitive load on billing staff and creates a defensible audit trail.

Patient eligibility checking is another area where process design matters. Confirming that a patient’s private medical insurance policy covers PDT for malignant skin lesions – before the treatment session – avoids the situation where a treatment is delivered and billed, only for the insurer to decline on the grounds that the patient’s plan does not cover that procedure. This is particularly relevant for Vitality Health, WPA, and smaller insurer plans where dermatology benefits may differ from Bupa or AXA Health policies.

For practices managing both NHS and private dermatology patients, keeping the CCSD billing workflow clearly separated from NHS coding is important. NHS-based coding uses OPCS-4 procedure codes, not CCSD codes. Mixing the two frameworks – either in clinical records or in billing systems – is a source of confusion that can affect both claim accuracy and Care Quality Commission documentation standards. The CQC’s governance framework requires that clinical records accurately reflect the care provided, which includes correct procedural coding in private patient billing.

Reviewed against current CCSD schedule guidance, BAD clinical guidelines for photodynamic therapy, and NICE technology appraisal guidance for PDT in skin cancer management.

Expert Picks

Looking for a full overview of CCSD codes used in UK private practice? Bupa CCSD Codes Guide covers the structure of Bupa’s CCSD-based billing framework, code look-up tools, and submission best practices for private practitioners.

Need to understand dermatology-specific practice management tools? Dermatology EMR Software explains how integrated clinical and billing systems support private dermatology workflows, from patient records to insurance claim submission.

Want to reduce claim errors and rejections across your practice? Claims Management Software outlines how linking clinical documentation to billing codes helps practices manage CCSD claim accuracy and reduce insurer queries.

Managing CQC compliance alongside billing requirements? CQC Inspection Checklist provides a structured review of documentation and governance requirements relevant to private UK healthcare practices.

Conclusion

CCSD code S0607 photodynamic therapy malignant skin lesion is a precisely defined billing code with a clear threshold: four or more malignant lesions treated in a single session. Accurate application depends on three things done consistently – correct lesion counting and documentation before billing begins, appropriate ICD-10 diagnosis code pairing, and pre-authorisation confirmation from the relevant UK private insurer.

The adjacent codes S0605 and S0606 serve the same treatment in different session sizes, so selecting the right code is always a documentation question first. When clinical records accurately capture lesion count, diagnosis, treatment details, and the clinician’s credentials, the billing step becomes a straightforward process rather than a source of claim errors.

For private dermatology practices managing regular PDT volumes, the difference between a clean claim and a delayed one often comes down to process design – structured treatment records, consistent pre-authorisation workflows, and a billing system that connects clinical data to the invoice. Building these habits into everyday practice protects revenue and reduces the administrative burden of managing insurer queries.

Frequently Asked Questions